ARTELO BIOSCIENCES, INC. (ARTL) › Shareholders' EquityARTELO BIOSCIENCES, INC. (ARTL) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2014: $14.7K2015: $15.9K2016: -$13.8K2017: $544.8K2018: -$135.0K2019: $5.46M2020: $3.88M2021: $27.17M2022: $19.40M2023: $11.75M2024: $2.86M2025: -$1.27M-$1.27M2014Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025-$1.27M-144.5%2024$2.86M-75.7%2023$11.75M-39.4%2022$19.40M-28.6%2021$27.17M+601.1%2020$3.88M-29.0%2019$5.46M+4145.2%2018-$135.0K-124.8%2017$544.8K+4048.1%2016-$13.8K-186.8%2015$15.9K+7.9%2014$14.7K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share